West Virginia 340B laws

Four West Virginia laws name the 340B program. Here is what each one does, who it applies to and where to read it.

W. Va. Code 33-51-3 and 33-51-9

A pharmacy benefit manager or other third-party payer may not pay a 340B entity less than similar pharmacies outside the program, charge it fees or chargebacks for taking part, or interfere with a patient's choice to get 340B drugs from it.

Bill
SB 489
Act
Acts 2019, ch. 145
Session
2019
Signed
1 March 2019
In effect
26 February 2019
Applies to
Pharmacy benefit managers and other third-party payers, Medicaid managed care organizations included
Limits
Fee-for-service Medicaid is not a third party under the section; a Medicaid managed care organization is. Does not apply to claims under an ERISA employee benefit plan. The acts of 2021 and 2022 that amend the section are listed.

shall not reimburse the 340B entity for pharmacy-dispensed drugs at a rate lower than that paid for the same drug to pharmacies similar in prescription volume that are not 340B entities

From the law’s text

W. Va. Code 33-51-3 and 33-51-9

A pharmacy benefit manager or other third party may not pay a 340B entity less than similar pharmacies, charge it fees or adjustments for taking part in 340B, interfere with a patient's choice to use it, or keep a pharmacy out of its network or cut its payment for dispensing 340B drugs.

Bill
HB 2263
Act
Acts 2021, ch. 164
Session
2021
Signed
9 April 2021
In effect
28 June 2021
Applies to
Pharmacy benefit managers and other third parties that pay for 340B drugs
Limits
Applies to policies and contracts delivered, amended or renewed on or after January 1, 2022. For the patient-choice rule, fee-for-service Medicaid is not a third party; Medicaid managed care plans are.

A pharmacy benefit manager, or any other third party, that reimburses a 340B entity for drugs that are subject to an agreement under 42 U.S.C. ยง 256b shall not reimburse the 340B entity for pharmacy-dispensed drugs at a rate lower than that paid for the same drug to pharmacies similar in prescription volume that are not 340B entities

From the law’s text

W. Va. Code 33-51-3, 33-51-9 and 33-51-13

A pharmacy benefit manager may not pay a 340B entity less than pharmacies of similar volume outside the program, or charge it fees, chargebacks or other adjustments; those include added requirements and a 340B modifier or resubmission on a claim. It may not discriminate against a 340B entity in a way that interferes with a patient's choice. The rule covers the state employee insurance agency.

Bill
HB 4112
Act
Acts 2022, ch. 159
Session
2022
Signed
30 March 2022
In effect
10 June 2022
Applies to
Pharmacy benefit managers
Limits
Applies to policies and contracts delivered or renewed on or after January 1, 2023. Medicaid may still prevent duplicate discounts, and the patient-choice rule does not cover fee-for-service Medicaid.
Enforcement
The Insurance Commissioner's rules set penalties, fines and loss of licence among them, for breaches of the article.

shall not reimburse the 340B entity for pharmacy- dispensed drugs at a rate lower than that paid for the same drug to pharmacies similar in prescription volume that are not 340B entities

From the law’s text

W. Va. Code 60A-8-6a

A manufacturer, its agent or affiliate may not deny, restrict or prohibit a 340B drug reaching a location that a 340B entity has authorized to receive it, and may not require claims or utilization data as a condition.

Bill
SB 325
Act
Acts 2024, ch. 93
Session
2024
Signed
27 March 2024
In effect
6 June 2024
Applies to
Drug manufacturers, their agents and affiliates
Limits
Does not apply where the U.S. Department of Health and Human Services prohibits the delivery. Data that the department requires is allowed. Limited distribution required by 21 U.S.C. 355-1 is allowed.
Enforcement
A civil penalty of $50,000 for each violation; each package of drugs counts once. The Board of Pharmacy may investigate complaints. There is no private right of action.

A manufacturer, agent, or affiliate of such manufacturer shall not, either directly or indirectly, deny, restrict, or prohibit the acquisition of a 340B drug by, or delivery of a 340B drug to, a location authorized by a 340B entity to receive such 340B drug, unless the receipt of the 340B drug is prohibited by the United States Department of Health and Human Services

From the law’s text

Plain-language summaries, not legal advice. Laws change, and court rulings on them are not covered here. Read the state’s own page before you rely on one.

See something missing or out of date? Tell us.